Royalty Pharma Dividends and Buybacks
Dividend criteria checks 2/6
Royalty Pharma is a dividend paying company with a current yield of 3.2% that is well covered by earnings. Next payment date is on 10th December, 2024 with an ex-dividend date of 15th November, 2024.
Key information
3.2%
Dividend yield
1.3%
Buyback Yield
| Total Shareholder Yield | 4.5% |
| Future Dividend Yield | 3.5% |
| Dividend Growth | 20.2% |
| Next dividend pay date | 10 Dec 24 |
| Ex dividend date | 15 Nov 24 |
| Dividend per share | €0.768 |
| Payout ratio | 32% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, RPD has been paying a dividend for less than 10 years.
Growing Dividend: RPD's dividend payments have increased, but the company has only paid a dividend for 4 years.
Dividend Yield vs Market
| Royalty Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (RPD) | 3.2% |
| Market Bottom 25% (DE) | 1.7% |
| Market Top 25% (DE) | 4.8% |
| Industry Average (Pharmaceuticals) | 1.4% |
| Analyst forecast (RPD) (up to 3 years) | 3.5% |
Notable Dividend: RPD's dividend (3.2%) is higher than the bottom 25% of dividend payers in the German market (1.69%).
High Dividend: RPD's dividend (3.2%) is low compared to the top 25% of dividend payers in the German market (4.79%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (32.5%), RPD's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: RPD is paying a dividend but the company has no free cash flows.